159 related articles for article (PubMed ID: 38055623)
21. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.
Gu Y; Lian Y; Gu L; Chen L; Li X; Zhou L; Huang Y; Wang J; Huang Y
BMC Infect Dis; 2019 Mar; 19(1):216. PubMed ID: 30832595
[TBL] [Abstract][Full Text] [Related]
22. Cytokine release of peripheral blood mononuclear cells in children with chronic hepatitis B virus infection.
Hsu HY; Chang MH; Ni YH; Lee PI
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):540-5. PubMed ID: 10554120
[TBL] [Abstract][Full Text] [Related]
23. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
[TBL] [Abstract][Full Text] [Related]
25. [Observation of PD-1
He J; Yao YQ; Xia RX; Qiu TJ; Long L; Wang Y; Jiang Y
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):316-322. PubMed ID: 35462489
[No Abstract] [Full Text] [Related]
26. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
27. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection.
Yang F; Yu X; Zhou C; Mao R; Zhu M; Zhu H; Ma Z; Mitra B; Zhao G; Huang Y; Guo H; Wang B; Zhang J
PLoS Pathog; 2019 Apr; 15(4):e1007690. PubMed ID: 30998767
[TBL] [Abstract][Full Text] [Related]
30. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.
Schlaak JF; Tully G; Löhr HF; Gerken G; Meyer zum Büschenfelde KH
Clin Exp Immunol; 1999 Mar; 115(3):508-14. PubMed ID: 10193426
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation.
Roberts A; Bentley L; Tang T; Stewart F; Pallini C; Juvvanapudi J; Wallace GR; Cooper AJ; Scott A; Thickett D; Lugg ST; Bancroft H; Hemming B; Ferris C; Langman G; Robinson A; Chapman J; Naidu B; Pinkney T; Taylor GS; Brock K; Stamataki Z; Brady CA; Curnow SJ; Gordon J; Qureshi O; Barnes NM
Sci Rep; 2021 Feb; 11(1):4030. PubMed ID: 33597595
[TBL] [Abstract][Full Text] [Related]
32. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection.
Wakita T; Kakumu S; Yoshioka K; Ishikawa T; Ito Y; Shinagawa T
Digestion; 1992; 52(1):26-33. PubMed ID: 1426694
[TBL] [Abstract][Full Text] [Related]
33. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
[TBL] [Abstract][Full Text] [Related]
34. Immune response pattern varies with the natural history of chronic hepatitis B.
Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
[TBL] [Abstract][Full Text] [Related]
35. Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B.
Fu YL; Zhou SN; Hu W; Li J; Zhou MJ; Li XY; Wang YY; Zhang P; Chen SY; Fan X; Song JW; Jiao YM; Xu R; Zhang JY; Zhen C; Zhou CB; Yuan JH; Shi M; Wang FS; Zhang C
Hepatol Int; 2023 Oct; 17(5):1125-1138. PubMed ID: 36976426
[TBL] [Abstract][Full Text] [Related]
36. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of HBeAg in persistent HBV infection.
Chen LM; Fan XG; Ma J; He B; Jiang YF
Hepatol Int; 2017 Jan; 11(1):79-86. PubMed ID: 27193024
[TBL] [Abstract][Full Text] [Related]
38. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
39. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
40. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]